Skip to main content

Advertisement

SpringerLink
Log in

Ovulation Induction for the General Gynecologist

  • Invited Review Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

The practice of ovulation induction often falls to the reproductive endocrinology and infertility specialist. However, attitudes toward the evaluation and treatment of infertility has shifted among general obstetrician-gynecologists (OB-GYN). This review discusses the underlying scientific basis of anovulation and clinical guidelines regarding the use of different medications for the purpose of promoting follicular recruitment and ovulation for the general OB-GYN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Thoma ME, McLain AC, Louis JF, et al. The prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99(5):1324–1331.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lindsay TJ, Vitrikas KR. Evaluation and treatment of infertility. Am Fam Physician. 2015;91(5):308–14.

    PubMed  Google Scholar 

  3. Amer SA, Li TC, Metwally M, et al. Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome. Hum Reprod. 2009;24(1):219–25.

    Article  PubMed  CAS  Google Scholar 

  4. Eldein HN. Family physicians’ attitude and practice of infertility management at primary care—Suez Canal University, Egypt. Pan Afr Med J 2013;15:106.

    PubMed  Google Scholar 

  5. National Collaborating Centre for Women’s and Children’s Health (UK). Ovulation disorders. In: Fertility: Assessment and treatment for people with fertility problems. London: Royal College of Obstetricians & Gynaecologists; 2013.

  6. Mesiano S, Jones EE. Chapter 55: The female reproductive system. In: Boron WF, Boulpaep EL, editors. Medical physiology. 3rd ed. Philadelphia: Elsevier; 2017.

    Google Scholar 

  7. Speroff L, Fritz M, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott, WIlliams & Wilkins; 2011.

    Google Scholar 

  8. Bao B, Garverick HA. Expression of steroidogenic enzyme and gonadotropin receptor genes in bovine follicles during ovarian follicular waves: a review. J Anim Sci. 1998;76(7):1903–21.

    Article  PubMed  CAS  Google Scholar 

  9. Roy SK, Treacy BJ. Isolation and long-term culture of human preantral follicles**Supported by grant HD 18165 (to S.K.R.) from the national institutes of health, Bethesda, Maryland. Fertil Steril. 1993;59(4):783–90.

    Article  PubMed  CAS  Google Scholar 

  10. Martinez AM, Lindheim SR. Induction of ovulation. In: Falcone T, Hurd WW, editors. Clinical reproductive medicine and surgery: a practical guide. 2nd ed. London: Springer; 2013.

    Google Scholar 

  11. Brown JB. Pituitary control of ovarian function–concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol. 1978;18(1):46–54.

    Article  PubMed  CAS  Google Scholar 

  12. Niswender GD, Juengel JL, Silva PJ, et al. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev. 2000;80(1):1–29.

    Article  PubMed  CAS  Google Scholar 

  13. Deveci CD, Demir B, Sengul O, et al. Clomiphene citrate ‘stair-step’ protocol vs. traditional protocol in patients with polycystic ovary syndrome: a randomized controlled trial. Arch Gynecol Obstet. 2015;291(1):179–84.

    Article  PubMed  CAS  Google Scholar 

  14. Dong X, Zheng Y, Liao X, et al. Does progesterone-induced endometrial withdrawal bleed before ovulation induction have negative effects on IUI outcomes in patients with polycystic ovary syndrome? Int J Clin Exp Pathol. 2013;6(6):1157–63.

    PubMed  PubMed Central  CAS  Google Scholar 

  15. Moy I, Ekpo G. Clomiphene citrate use for ovulation induction: When, why, and how? Contemporary OB/GYN 2011.

  16. Jones T, Gualtieri M, Bruno-Gaston J, et al. Evaluation of clomiphene citrate stair-step protocol for ovulation induction. Fertil Steril. 2014;102(3):e138.

    Article  Google Scholar 

  17. Diamond MP, Kruger M, Santoro N, et al. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol. 2012;119(5):902–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Athaullah N, Proctor M, Johnson NP. Oral versus injectable ovulation induction agents for unexplained subfertility. Cochrane Database Syst Rev. 2002;3:CD003052.

    Google Scholar 

  19. Sallam HN, Abdel-Bak M, Sallam NH. Does ovulation induction increase the risk of gynecological cancer? Facts Views Vis Obgyn. 2013;5(4):265–73.

    PubMed  PubMed Central  CAS  Google Scholar 

  20. Seyedoshohadaei F, Zandvakily F, Shahgeibi S. Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation. Iran J Reprod Med. 2012;10(6):531–6.

    PubMed  PubMed Central  CAS  Google Scholar 

  21. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119–29.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Zakherah MS, Nasr A, El Saman AM, et al. Clomiphene citrate plus tamoxifen versus laparoscopic ovarian drilling in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet. 2010;108(3):240–3.

    Article  PubMed  CAS  Google Scholar 

  23. de Paula Guedes Neto E, Savaris RF, von Eye Corleta H, et al. Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome. Fertil Steril. 2011;96(3):769–73.

    Article  PubMed  CAS  Google Scholar 

  24. Dhaliwal LK, Suri V, Gupta KR, et al. Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome. J Hum Reprod Sci. 2011;4(2):76–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. El-Gharib MN, Mahfouz AE, Farahat MA. Comparison of letrozole versus tamoxifen effects in clomiphen citrate resistant women with polycystic ovarian syndrome. J Reprod Infertil. 2015;16(1):30–5.

    PubMed  PubMed Central  Google Scholar 

  26. Kar S. Current evidence supporting “letrozole” for ovulation induction. J Hum Reprod Sci. 2013;6(2):93–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Finn RS, Crown JP, Lang I, et al. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol. 2015;16(1):25–35.

    Article  PubMed  CAS  Google Scholar 

  28. Roque M, Tostes AC, Valle M, et al. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis. Gynecol Endocrinol. 2015;31(12):917–21.

    Article  PubMed  CAS  Google Scholar 

  29. Penzias A, Bendikson K, Butts S, et al. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): A guideline. Fertil Steril. 2017;108(3):426–41.

    Article  CAS  Google Scholar 

  30. Tock L, Carneiro G, Pereira AZ, et al. Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome. Int J Endocrinol. 2014;2014:620605.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Morin-Papunen L, Rantala AS, Unkila-Kallio L, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab. 2012;97(5):1492–500.

    Article  PubMed  CAS  Google Scholar 

  32. Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;1(3):117–28.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Sohrabvand F, Ansari S, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21(6):1432–5.

    Article  PubMed  CAS  Google Scholar 

  34. Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo). 2015;70(11):765–9.

    Article  Google Scholar 

  35. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23(3):462–77.

    Article  Google Scholar 

  36. Infertility in women. [Internet]; 2012. http://umm.edu/health/medical/reports/articles/infertility-in-women. Accessed 12 Mar 2018.

  37. Practice Committee of American Society for Reproductive Medicine. Use of exogenous gonadotropins in anovulatory women: a technical bulletin. Fertil Steril. 2008;90(5 Suppl):S7–12.

    Google Scholar 

  38. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373(13):1230–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Kawwass JF, Loucks TL, Berga SL. An algorithm for treatment of infertile women with polycystic ovary syndrome. Middle East Fertil Soc J. 2010;15(4):231–9.

    Article  Google Scholar 

  40. Palshetkar N, Roongta N. Protocols for ovulation induction. In: Mumbai Obstetric and Gynecological Society; 2011.

  41. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev. 1997;18(1):71–106.

    PubMed  CAS  Google Scholar 

  42. Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update. 2006;12(4):333–40.

    Article  PubMed  CAS  Google Scholar 

  43. Birch Petersen K, Pedersen NG, Pedersen AT, et al. Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction. Reprod Biomed Online. 2016;32(6):563–83.

    Article  PubMed  Google Scholar 

  44. Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol. 2011;54(4):685–95.

    Article  PubMed  Google Scholar 

  45. Lee Y, Kim Y, Chang J, et al. Changes in oral mucosal MUCI expression and salivary hormones throughout the menstrual cycle. Oral Disease. 2015;21(962):968.

    Google Scholar 

  46. Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10(1):32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Al-Inany H, Youssef MA, Ayeleke RO, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4:CD001750.

    PubMed  Google Scholar 

  48. Practice Committee of the American Society for Reproductive Medicine. Fertility drugs and cancer: a guideline. Fertil Steril. 2016;106(7):1617–26.

    Article  CAS  Google Scholar 

  49. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013;8:CD008215.

    Google Scholar 

  50. Fernandez H, Morin-Surruca M, Torre A, et al. Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. Reprod Biomed Online. 2011;22(6):556–68.

    Article  PubMed  Google Scholar 

  51. Farquhar C, Brown J, Marjoribanks J, Vandekerckhove P. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2012;6:CD001122.

    Google Scholar 

  52. Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100(2):341–8.

    Article  Google Scholar 

  53. Fortune JE. Ovarian follicular growth and development in mammals. Biol Reprod. 1994;50(2):225–32.

    Article  PubMed  CAS  Google Scholar 

  54. Chizen DR, Pierson R. Transvaginal ultrasonography and female infertility. In: The Global Library of Women’s Medicine; 2010.

  55. Su H, Yi Y, Wei T, et al. Detection of ovulation, a review of currently available methods. Bioeng Transl Med. 2017;2(3):238–46.

    PubMed  PubMed Central  CAS  Google Scholar 

  56. Tourville TW, Shultz SJ, Vacek PM, et al. Evaluation of an algorithm to predict menstrual-cycle phase at the time of injury. J Athl Train. 2016;51(1):47–56.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Hassan A, Shehata N, Wahba A. Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial. Hum Fertil (Camb). 2017;20(1):37–42.

    Article  Google Scholar 

  58. Kumar P, Sait SF. Luteinizing hormone and its dilemma in ovulation induction. J Hum Reprod Sci. 2011;4(1):2–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Kamath MS, Maheshwari A, Bhattacharya S, Lor KY, Gibreel A. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Cochrane Database Syst Rev. 2017;1:CD008528.

    Google Scholar 

  60. An KC. Selective estrogen receptor modulators. Asian Spine J. 2016;10(4):787–91.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Suginami H, Kitagawa H, Nakahashi N, et al. A clomiphene citrate and tamoxifen citrate combination therapy: a novel therapy for ovulation induction. Fertil Steril. 1993;59(5):976–9.

    Article  PubMed  CAS  Google Scholar 

  62. Franik S, Kremer J, Nelen W, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014;24(2):CD010287.

    Google Scholar 

  63. Pritts EA, Yuen AK, Sharma S, et al. The use of high dose letrozole in ovulation induction and controlled ovarian hyperstimulation. ISRN Obstet Gynecol. 2011. https://doi.org/10.5402/2011/242864.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Fabian CJ. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract. 2007;61(12):2051–63.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. He Q, Liang L, Zhang C, et al. Effects of different doses of letrozole on the incidence of early-onset ovarian hyperstimulation syndrome after oocyte retrieval. Syst Biol Reprod Med. 2014;60(6):355–60.

    Article  PubMed  CAS  Google Scholar 

  66. Misso ML, Costello MF, Garrubba M, et al. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(1):2–11.

    Article  PubMed  CAS  Google Scholar 

  67. Pawlyk AC, Giacomini KM, McKeon C, et al. Metformin pharmacogenomics: current status and future directions. Diabetes. 2014;63(8):2590–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Barbieri RL. Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is. J Clin Endocrinol Metab. 2007;92(9):3399–401.

    Article  PubMed  CAS  Google Scholar 

  69. Cedrin-Durnerin I, Massin N, Galey-Fontaine J, et al. Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment. Hum Reprod. 2006;21(11):2941–7.

    Article  PubMed  CAS  Google Scholar 

  70. Follicle stimulating hormone and luteinizing hormone (intramuscular route, subcutaneous route) [Internet]: Truven Health Analytics; c20172018]. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010378/. Accessed 25 Jan 2018.

Download references

Author information

Authors and Affiliations

  1. Division of Reproductive Endocrine Infertility, Department of Obstetrics and Gynecology, Boonshoft School of Medicine, Wright State University, 128 Apple St, Suite 3800 Weber CHE, Dayton, OH, 45409, USA

    Steven R. Lindheim, Tanya L. Glenn & Megan C. Smith

  2. Department of Obstetrics and Gynecology, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, 4881 Sugar Maple Dr, Dayton, OH, 45433, USA

    Tanya L. Glenn

  3. Department of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA

    Pascal Gagneux

Authors
  1. Steven R. Lindheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tanya L. Glenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Megan C. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pascal Gagneux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven R. Lindheim.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Additional information

Steven R. Lindheim, MD, MMM is a professor in Division of Reproductive Endocrine Infertility, Department of Obstetrics and Gynecology, Boonshoft School of Medicine at the Wright State University, Dayton, OH, USA; Tanya L. Glenn, MD, Division of Reproductive Endocrine Infertility, Department of Obstetrics and Gynecology, Boonshoft School of Medicine at the Wright State University, Dayton, OH, USA and Department of Obstetrics and Gynecology, Wright-Patterson Air Force Base at the Wright-Patterson Medical Center, Dayton, OH, USA; Megan C. Smith, M.P.H, Division of Reproductive Endocrine Infertility, Department of Obstetrics and Gynecology, Boonshoft School of Medicine at the Wright State University, Dayton, OH, USA; Pascal Gagneux, Ph.D., Department of Cellular and Molecular Medicine at the University of California San Diego, San Diego, CA, USA.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lindheim, S.R., Glenn, T.L., Smith, M.C. et al. Ovulation Induction for the General Gynecologist. J Obstet Gynecol India 68, 242–252 (2018). https://doi.org/10.1007/s13224-018-1130-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-018-1130-8

Keywords

Search

Navigation